Telomerase activity and telomere length in AML-M3 patients
-
Hamidollah Ghaffari
,
Abdol H. Jamialahmadi
,
Nilofar Shayan-Asl
,
Kamran Alimoghaddam
,
Ardeshir Ghavamzadeh
Abstract
Introduction: The telomeric DNA together with its associated proteins protects the chromosome ends from degradation or aberrant recombination. Telomerase and telomere are closely associated with development of cancers. In this study we aim to investigate the significance of telomerase activity (TA) and telomere length (TL) in patients with acute promyelocytic leukemia (APL).
Methods: Peripheral blood samples were taken from 20 APL patients during the diagnosis and from 25 healthy normal individuals at different age ranges. Telomerase activity (TA) was assessed by TRAP-ELISA and –PAGE procedures. Genomic DNA isolated from patient mononuclear cells was digested with Rsa1 and Hinf1 restriction enzymes; electrophoresis was performed in 0.8% agarose gels, and telomere length (TL) was determined by southern analysis using a Chemiluminescence-based assay.
Results: As oppose to the normal individuals, telomerase activity was detected in peripheral blood mononuclear cells of all APL patients (P<0.001). Marked differences were observed in the sizes of the telomere length in the normal blood cells and APL leukemic cells. The leukemic cells of 18 of 20 (90%) patients with APL showed a significant reduction in the length of telomeric DNA, ranging from 2.3 to 6.7 kbp (median 3.5 kbp), while the telomere length in healthy normal individuals was 9.1 to 14.8 kbp (median 11.6 kbp) (P<0.000). In healthy individuals, the average TL was found to vary with age, and the rate of telomere shortening was age dependent.
Conclusions:Telomere length shortening and Telomerase up-regulation are closely associated with acute promyelocytic leukemia; therefore, they may be used as potential markers for diagnostic, prognostic and for therapeutic intervention in APL patients.
de Lange T. Protection of Mammalian Telomeres. Oncogene. 2002. 21(4): 532– 540.
Griffith JD, et al. Mammalian Telomeres End in a Large Duplex Loop. Cell. 1999. 97: 503–514.
Sedivy JM. Can Ends Justify the Means? Telomeres and the Mechanisms of Replicative Senescence and Immortalization in Mammalian Cells. Proc Natl Acad Sci U S A. 1997. 95: 9078- 9081.
Hahn WC, Stewart SA, Brooks MW, et al. Inhibition of Telomerase Limits the Growth of Human Cancer Cells. Nat Med. 1999. 5: 1164- 1170.
Djojosubroto MW, Choi YS, Lee HW, et al. Telomeres and Telomerase in Aging, Regeneration and Cancer. Mol Cells. 2003. 15: 164- 175.
Hahn WC. Role of Telomeres and Telomerase in the Pathogenesis of Human Cancer. J Clin Oncol. 2003. 21: 2034- 2043.
Kim SH, Kaminker P, Campisi J. Telomeres, Aging and Cancer: In Search of a Happy Ending. Oncogene. 2002; 21: 503- 511.
Zakian VA. Structure and Function of Telomeres. Annu. Rev. Genet., 1989. 23: 579–604.
de Lange T. Activation of Telomerase in a Human Tumor. Proc. Natl. Acad. Sci. USA, 1994. 91: 2882–2885.
Harley CB, Villeponteau B. Telomere and Telomerase in Aging and Cancer. Curr. Opin. Genet. Dev.; 1995. 5: 249– 255.
Shay JW, Wright WE. Telomerase activity in human cancer. Curr. Opin. Oncol. 1996; 8: 66-71.
Pandita TK, Hall EJ, Hei TK, et al. Chromosome end-to- end associations and telomerase activity during cancer progression in human cells after treatment with alpha-particles simulating radon progeny. Oncogene. 1996. 13 (7): 1423– 1430.
Dahse R, Fiedler W, Ernst G. Telomeres and Telomerase: Biological and Clinical Importance. Clin. Chem. 1997; 43: 708–714.
Engelhardt M, Albanell J, Drullinsky P, et al. Relative Contribution of Normal and Neoplastic Cells Determines Telomerase Activity and Telomere Length in Primary Cancers of the Prostate, Colon, and Sarcoma. Clin Cancer Res. 1997; 3: 1849- 1857.
Engelhardt M, Drullinsky P, Guillem J, Moore MAS. Telomerase and Telomere Length in the Development and Progression of Premalignant Lesions to Colorectal Cancer. Clin Cancer Res 1997b; 3: 1931- 1941.
Albanell J, Lonardo F, Rusch V, et al. High Telomerase Activity in Primary Lung Cancers: Association with Increased Cell Proliferation Rates and Advanced Pathologic Stage. J Natl Cancer Inst. 1997; 89:1609-1615.
Gertler R, Roenberg R, Stricker D. Telomere Length and Human Telomerase Reverse Transcriptase Expression as Markers for Progression and Prognosis of Colorectal Carcinoma. J. Clin Oncol. 2004; 22: 1807-1814.
Kammori M, Takubo K, Nakamura K, et al. Telomerase Activity and Telomere Length in Benign and Malignant Human Thyroid Tissues. Cancer Letters. 2000; 175-181.
Wu X, Amos CI, Zhu Y, et al. Telomere Dysfunction: A Potential Cancer Predisposition Factor. J Natl Cancer Inst. 2003; 95: 1211–1218.
Ohyashiki JH, Sashida G, Tauchi T, et al. Telomeres and Telomerase in Hematologic Neoplasia. Oncogene; 2002; 21: 680-687.
Engelhardt M, MacKenzie K, Drullinsky P, et al. Telomerase Activity and Telomere Length in Acute and Chronic Leukemia, pre and post-ex Vivo Culture. Cancer Res; 2000; 60: 610-617.
Zhang W, Piatyszek MA, Kobayashi T, et al. Telomerase Activity in Human Acute Myelogenous Leukemia: Inhibition of Telomerase Activity by Differentiation-inducing Agents. Clin Cancer Res; 1996; 2: 799–803.
Xu D, Gruber A, Peterson C, et al. Telomerase Activity and the Expression of Telomerase Components in Acute Myelogenous Leukaemia. Br J Haematol; 1998; 102: 1367– 1375.
Huh HJ, Huh JW, Yoo ES, et al. hTERT mRNA Levels by Real-time RT-PCR in Acute Myelogenous Leukemia. Am J Hematol; 2005; 79: 267-273.
Henson JD, Neumann AA, Yeager TR, et al. Alternative Lengthening of Telomeres in Mammalian Cells. Oncogene; 2002; 21: 598-610.
Bryan TM, Englezou A, Gupta J, et al. Telomere Elongation in Immortal Human Cells without Detectable Telomerase Activity. EMBO J; 1995; 14: 4240-4248.
Cerone MA, Londono-Vallejo JA, Bacchetti S. Telomere Maintenance by Telomerase and by Recombination Can Coexist in Human Cells. Hum Mol Genet. 2001; 10:1945- 1952.
Wu KD, Orme LM, Shaughnessy J, et al. Telomerase and Telomere Length in Multiple Myeloma: Correlations with Disease Heterogeneity, Cytogenetic Status, and Overall survival. Blood. 2003; 101:4982- 4989.
| Files | ||
| Issue | Vol 3, No 2 (2009) | |
| Section | Articles | |
| Keywords | ||
| Telomere length Telomerase activity acute promyelocytic leukemia TRAP assay | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
